Catch up on the top radiology content of the past week.
|Articles|September 30, 1998
Klein to lead GE nuclear unit
Beth Klein has been tapped to lead the nuclear medicine and PET division of GE Medical Systems, replacing Sharon Banaszewski, who has been reassigned to a position overseeing the Milwaukee company’s supplier relationships. Klein is a long-time GE
Advertisement
Beth Klein has been tapped to lead the nuclear medicine and PET division of GE Medical Systems, replacing Sharon Banaszewski, who has been reassigned to a position overseeing the Milwaukee companys supplier relationships. Klein is a long-time GE executive who previously was general manager of CT sales and marketing in Europe. In her new role, Klein will oversee a GE nuclear medicine program that will be greatly expanded by the acquisition of Elscints nuclear medicine division (see story, page 1).
Advertisement
Related to this article
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
3
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
4
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
5